Corcept Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Alaunos Therapeutics USD -755000 395K 2024-12
ANI Pharmaceuticals USD -4378000 16.14M 2024-12
Ardelyx USD 8.12M 5.89M 2024-12
Aurora Cannabis CAD 36.22M 38.61M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
J&J USD 13.63B 9.74B 2025-03
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Merck USD 4.3B 369M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Pacira USD 24.7M 164.23M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12



Corcept Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.